Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cellsEdris Choupani, Arshad Hosseini|PLoS ONE|2022Cited by 27
The effect of ribociclib on the expression levels of miR-141 and CDK4/6-USP51 signaling pathway genes in MCF-7 and MDA-MB-231 cellsShayeste Sadat Baghermanesh, Arshad Hosseini|PLoS ONE|2024Cited by 1